Acon Investments / Newbridge Academy Centennial Fund Andean Partners P.O. Box 110367 1133 Connecticut Avenue, NW, Suite 700 Research Triangle Park, NC 27609-0367 Washington, DC 20036 Ph: 919-933-3100 Ph: 202-454-1100 Fax: 202-454-1101 Web: www.academyfunds.com Email: [email protected] Company Contacts: Company Contacts: Ginns, Jonathan J. Managing Director Kline, Glenn J. [email protected] Senior Managing Director [email protected] Aronson, Bernard Partner Clannamea, John Senior Managing Director [email protected] Adams Street Partners LLC Caplice, Matt Senior Analyst One North Wacker Drive Suite 2200 [email protected] Chicago, IL 60606-2807 Ph: 312-553-7890 Fax: 312-553-7891 Brooks, Thomas Web: www.adamsstreetpartners.com Partner Email: [email protected] Johnson, Gregory Company Contacts: French, Bon Biotechnology Portfolio: Chief Executive Officer and Chief Investment Officer Biolex Inc.; Pilot Biotechnologies Inc.; VetXcel; Taylor, Craig Xanthon Inc.; Zymotech Partner Stages Funded: Gould, Terry Partner Series A-B Biotechnology Portfolio: Academy Funds Aviron Inc.; BioTransplant Inc.; CardioVention Inc.; CombiChem Inc.; CombinatoRx Inc.; DepoTech 111 North Chestnut Street, Suite 105 Corporation; Eligix Inc.; FemRx Inc.; Galileo Winston-Salem, NC 27101 Laboratories Inc.; Heartport Inc.; Instrumentation Ph: 336-748-9991 Fax: 336-748-9909 Metrics Inc.; IntraBiotics Pharmaceuticals Inc.; Web: www.academyfunds.com Pharmacyclics Inc.; Myogen Inc.; NxStage Medical Inc.; Email: [email protected] Pharmacyclics Inc.; Revivant Corporation; Sensys Medical Inc.; Somatogen Inc.; Spinal Dynamics Company Contacts: Corporation; Symphonix Devices Inc.; Vivant Medical Inc. Walters, Brad Principal Stages Funded: [email protected] Series A-B, Series C-D Biotechnology Portfolio: Admetech; Amplistar Inc.; Anasazi; Curry Areas of Focus: Pharmaceuticals; Kucera Pharmaceutical Company; Therapeutics, Vaccines, Diagnostics, Medical devices Pilot Therapeutics Inc.; Targacept Inc.; VetXcel Stages Funded: Seed, Series A-B Areas of Focus: Therapeutics, Vaccines, Diagnostics, Medical devices, Platform technologies, Agriculture, Chemicals/reagents/supplies BioAbility® & BioWorld® 4 Adams, Harkness and Hill Inc. Advanced Technology Ventures – Palo Alto, CA Four Embarcadero Center, Suite 3300 San Francisco, CA 94111 485 Ramona Street Ph: 415-229-7171 Fax: 415-229-0635 Palo Alto, CA 94301 Web: www.ahh.com Ph: 650-321-8601 Fax: 650-321-0934 Web: www.atv-ventures.com Company Contacts: Email: [email protected] Headquarters Site Adams, John Chairman Company Contacts: McMahon, Timothy Carusi, Michael A. President and Chief Executive Officer General Partner [email protected] Biotechnology Portfolio: Schiller, Pieter Abgenix Inc.; Adolor Corporation; Alkermes Inc.; General Partner Angiotech Pharmaceuticals; AtheroGenics Inc.; [email protected] Becton Dickinson & Company; BioSphere Medical Inc.; Biosite Inc.; Cardia Science Inc.; Celgene George, Jean Corporation; Cephalon Inc.; Cholestech Corporation; Partner Conceptus Inc.; Cytyc Corporation; Digene [email protected] Corporation; Genentech Inc.; DURECT Corporation; Edwards Lifesciences Corporation; IDEC Pharmaceuticals Corporation; Guidant Corporation; Biotechnology Portfolio: ImmunoGen Inc.; Inamed Corporation; Integra Afferon Corporation; Anthra Pharmaceuticals Inc.; LifeSciences Corporation; InterMune Inc.; Kosan Ardais Corporation; Cardiac Support Systems Inc.; Biosciences Inc.; MedImmune Inc.; Mentor Cepheid Inc.; Cerebral Vascular Applications Inc.; Circe Corporation; Merit Medical Systems Inc.; North Biomedical Inc.; CollaGenex Pharmaceuticals Inc.; American Scientific Inc.; Novoste Corporation; NPS Coulter Cellular Therapies Inc.; CytoLogix Corporation; Pharmaceuticals Inc.; OSI Pharmaceuticals Inc.; Cytyc Corporation; deNovis Inc.; eHealth Direct Inc.; Pharmacyclics Inc.; Protein Design Labs Inc.; Eligix Inc.; Emphasys Medical Inc.; Endius Inc.; Quinton Cardiology Systems Inc.; Scios Inc.; STAAR MicroVention Inc.; Novoste Corporation; Optobionics Surgical Company; SurModics Inc.; Tanox Inc.; Corporation; Percardia Inc.; Plexxikon Inc.; Purilens Thoratec Corporation; Vital Signs Inc.; XOMA Inc.; Synthon Chiragenics Corporation Corporation; ZOLL Medical Corporation Stages Funded: Seed, Series A-B, Series C-D, Mezzanine, Bridge Advanced Technology Ventures – Waltham, MA 1000 Winter Street, Suite 3700 Waltham, MA 02451 Ph: 781-290-0707 Fax: 781-684-0045 Web: www.atvcapital.com Email: [email protected] Company Contacts: Carusi, Michael A. General Partner [email protected] Schiller, Pieter J. General Partner [email protected] George, Jean Partner [email protected] BioAbility® & BioWorld® 5 Advantage Capital Partners – Advantage Capital Partners – Tampa, FL New York, NY One Hundred North Tampa Street, Suite 2410 521 Madison Avenue, 7th Floor Tampa, FL 33602 New York, NY 10022 Ph: 813-221-8700 Fax: 813-221-1606 Ph: 212-893-8600 Fax: 212-893-8700 Web: www.advantagecap.com Web: www.advantagecap.com Email: [email protected] Email: [email protected] Company Contacts: Company Contacts: Cockshutt, Timothy G. Murphy, Scott Managing Director Senior Vice President [email protected] [email protected] Garrett, Tate Senior Vice President Advantage Capital Partners – [email protected] New Orleans, LA Brown, Crichton W. Managing Director 909 Poydras Street, Suite 2230 New Orleans, LA 70112 Ph: 504-522-4850 Fax: 504-522-4950 Web: www.advantagecap.com Advantage Capital Partners – Email: [email protected] Headquarters Site St. Louis, MO 7733 Forsyth Boulevard, Suite 1850 Company Contacts: St. Louis, MO 63105 Brown, Crichton W. Ph: 314-725-0800 Fax: 314-725-4265 Managing Director Web: www.advantagecap.com [email protected] Email: [email protected] Stull, Steven T. Company Contacts: President [email protected] Bergmann, David W. Senior Managing Director [email protected] Biotechnology Portfolio: Angiorad LLC; Aquagene Inc.; Copharos Inc.; Entomos Zajac, Scott A. LLC; Gala Biotech; Image-Guided Neurologics Inc.; Managing Director Ischemic Technologies Inc.; Radiation Therapies LLC; [email protected] Stereotaxis Inc.; TomoTherapy Inc. Stages Funded: Seed, Series A-B, Series C-D, Mezzanine, Bridge, Buyout Areas of Focus: Therapeutics, Vaccines, Diagnostics, Medical devices, Agriculture, Manufacturing, Platform technologies, Agriculture, Chemicals/reagents/supplies, Regional investment BioAbility® & BioWorld® 6 Advent International Advent-Morro Equity Partners 75 State Street Banco Popular Building, 206 Tetuan Street, Boston, MA 02109 Suite 903 Ph: 617-951-9400 Fax: 617-951-0566 San Juan, PR 00902 Web: www.adventinternational.com Ph: 787-725-5285 Fax: 787-721-1735 Email: [email protected] Company Contacts: Company Contacts: Meduna, Cyril L. Fisherman, Jason S. General Partner Managing Director [email protected] [email protected] Fishman, Ricardo Mills, William C. Principal Partner [email protected] [email protected] Stages Funded: Kim, Howard Y. Associate Series A-B [email protected] Bednarski, Eric Affinity Capital Management Senior Associate [email protected] 901 Marquette Avenue, Suite 1810 Minneapolis, MN 55402 Bilyew, Ann M. Ph: 612-252-9900 Fax: 612-252-9911 [email protected] Web: www.affinitycapital.net/Default.htm Biotechnology Portfolio: Stages Funded: Achillion Pharmaceuticals Inc.; Aerogen Inc.; Ardais Seed Corporation; Anadys Pharmaceuticals Inc.; Array BioPharma Inc.; Arris Pharmaceutical Inc.; Astex Technology Ltd.; Aviron Inc.; Axys Pharmaceuticals Inc.; Cubist Pharmaceuticals Inc.; CV Therapeutics Agio Capital Partners I, LP Inc.; Cytyc Corporation; deCODE genetics Inc.; D- Pharm Ltd.; Enanta Pharmaceuticals Inc.; EPIX 5050 Lincoln Drive, Suite 420 Medical Inc.; Exelixis Inc.; GPC Biotech AG; ILEX Edina, MN 55436 Oncology Inc.; MDeverywhere Inc.; Med e-Manager Ph: 952-938-1628 Fax: 952-933-6066 Corporation; MedVantx Inc.; Mitotix Inc.; Web: www.agio-capital.com Neurogenetics Inc.; Osteotech Inc.; Pharming Group Email: [email protected] NV; Ribozyme Pharmaceuticals Inc.; Stereotaxis Inc.; Telik Inc.; Trinity Pharmaceuticals Ltd.; Tropon Company Contacts: KG; Vanguard Medica Group plc; Variagenics Inc. Gudorf, Kenneth F. President and Chief Executive Officer Stages Funded: [email protected] Seed, Series A-B, Series C-D, Mezzanine Haas, Donald M. Managing Director [email protected] Biotechnology Portfolio: Biovance Technologies Inc. Stages Funded: Seed, Buyout BioAbility® & BioWorld® 7 Alafi Capital Company Alliance Technology Ventures P.O. Box 7338 8995 Westside Parkway, Suite 200 Berkeley, CA 94707 Alpharetta, GA 30004 Ph: 510-653-7425 Fax: 510-653-6231 Ph: 678-336-2000 Fax: 678-336-2001 Web: www.alafi.com Web: www.atv.com Email: [email protected] Company Contacts: Company Contacts: Henos, Michael A. Alafi, Christopher Managing General Partner Managing Director Slawson, Michael Alafi, Moshe General Partner President and Chief Executive Officer [email protected] Hanley, Karen Seabrook, Conner Principal Administrative Partner [email protected] Biotechnology Portfolio: Biotechnology Portfolio: Amgen Inc.; Applied Biosystems Inc.; Biogen Inc.; Clinitrac; Coley Pharmaceutical Group; CpG Aderis Pharmaceuticals Inc.; Adeza Biomedical ImmunoPharmaceuticals/Coley Pharmaceutical Corporation; AtheroGenics Inc.; Discovery Group; Diagen; Everest Biomedical Instruments Inc.;